WWS
ABBV icon

Wellington Wealth Strategies’s AbbVie ABBV Stock Holding History

Wellington Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$364K Sell
1,882
-2,475
-57% -$455K 0.33% 45
2024
Q3 		$888K Buy
+4,357
New +$813K 0.67% 35
2024
Q2 		– Sell
-3,251
Closed -$592K – 50
2024
Q1 		$592K Sell
3,251
-2,413
-43% -$416K 0.28% 77
2023
Q4 		$878K Buy
+5,664
New +$826K 0.74% 35
2020
Q4 		$878K Buy
+5,664
New +$544K 0.74% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Wealth Strategies's ABBV Position: Q4 2024 in Review

Wellington Wealth Strategies reduced its AbbVie (ABBV) stake by 57% in Q4 2024, selling an estimated $455K and leaving 1,882 shares worth $364K. The position accounts for 0.33% of the portfolio, ranked #45.

Wellington Wealth Strategies first reported a position in ABBV in Q4 2020 and has held it in 5 quarters since. The position peaked at $888K in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Wellington Wealth Strategies held 1,882 shares of AbbVie worth $364K as of Q4 2024.
  • Wellington Wealth Strategies sold 2,475 AbbVie shares in Q4 2024, an estimated $455K.
  • AbbVie made up 0.33% of Wellington Wealth Strategies's portfolio in Q4 2024, its #45 holding.
  • Wellington Wealth Strategies first reported a position in AbbVie in Q4 2020 and has held it in 5 quarters since.
  • Wellington Wealth Strategies's AbbVie position peaked at $888K in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Wellington Wealth Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.